Granules India gets ANDA approval for colchicine capsules
The wholly-owned subsidiary of Granules India has received Abbreviated New Drug Application (ANDA) approval from the US Food & Drug Administration (USFDA) for colchicine capsules, 0.6 mg. The application was filed by Granules Pharmaceuticals, Inc. (GPI), a subsidiary of the company. According to the stock exchange filing, the capsule is equivalent to ‘mitigare capsules’, 0.6 […]